New Leaf Venture Partners, L.L.C. Rocket Pharmaceuticals, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $82.1 Million
- Q2 2024
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 150,706 shares of RCKT stock, worth $2.47 Million. This represents 3.95% of its overall portfolio holdings.
Number of Shares
150,706
Previous 118,242
27.46%
Holding current value
$2.47 Million
Previous $3.19 Million
1.85%
% of portfolio
3.95%
Previous 2.79%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
196Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$290 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$150 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$95.3 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$71 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.24B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...